Fennec Pharmaceuticals's total assets for Q3 2025 were $49.21M, an increase of 9.66% from the previous quarter. FENC total liabilities were $53.70M for the fiscal quarter, a 2.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.